Indeed, Plk3 has a tumor suppressor role in hepatocellular (HCC) and head and neck squamous cell carcinoma (HNSCC) [17–19], while overexpression was correlated with shortened relapse-free survival time in breast and ovarian cancer [20, 21]. This evidence concerns the gene PLK3 and hepatocellular carcinoma.